Becker's Healthcare July 9, 2024
Ashleigh Hollowell

Eighty-five days shy of October, the month when respiratory virus season typically begins in the U.S., the CDC and FDA have already made several key announcements about what clinicians can expect for the 2024-2025 round of vaccines for the infections that dominate during this time of year: influenza, respiratory syncytial virus and COVID-19.

Below are the most recent recommendations for the upcoming round of vaccines:


The 2024-2025 flu vaccines are recommended by the CDC for everyone 6 months of age and older. This year, the flu vaccine will likely transition back to a trivalent composition, removing the B/Yamagata lineage virus as a component.

“Influenza B viruses are classified into two lineages: B/Yamagata and B/Victoria,” a March FDA committee recommendation...

Today's Sponsors


Today's Sponsor


Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
90% of excess deaths attributed to COVID since 2020
Public Health Matters Video: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
How ultra-processed foods are devastating public health
Vaccination reduces risk of long COVID: Study
Loper Bright And The Death Of Deference In The Administration Of Health Policy

Share This Article